DARS-AS1: A Vital Oncogenic LncRNA Regulator with Potential for Cancer Prognosis and Therapy.
Article in International Journal of Medical Sciences (January 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Advances of radiotherapy combined with targeted therapy for nasopharyngeal carcinoma
Article in Radiation Medicine and Protection (December 2023)
Recent progress and the emerging role of lncRNAs in cancer drug resistance; focusing on signaling pathways
Article in Pathology - Research and Practice (November 2023)